Net sales were SEK 491.7 MSEK (506.6), a decrease of 2.9% compared to the equivalent period in 2023. Organic growth was -3.4% for the period. EBITA was 54.1 MSEK (64.5), an EBITA margin of 11.0% (12.7 ...
Net sales for the quarter amounted to MSEK 6 (9)Gross margin for the quarter decreased to 38% (51%)Operating loss amounted to MSEK -16 (-16)Earnings per share before and after dilution increased to ...
UPPSALA, SE / ACCESSWIRE / August 26, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, a pioneer and leader within ...
Net sales for the quarter amounted to MSEK 6 (9)Gross margin for the quarter decreased to 38% (51%)Operating loss ...
On April 18, 2024, Hamlet BioPharma secured continued large-scale Alpha1 peptide production in an agreement with Polypeptide Group. The new production, at a larger scale, will be essential for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback